News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
New Insights from Taiki Hakozaki et al. on Gut Microbiota’s Role in NSCLC – IASLC
Taiki Hakozaki/researchgate.net
Jul 24, 2025, 17:17

New Insights from Taiki Hakozaki et al. on Gut Microbiota’s Role in NSCLC – IASLC

International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn about a paper by Taiki Hakozaki et al. published in the Journal of Thoracic Oncology:

“The role of gut microbiota as a potential biomarker for first-line treatment selection in NSCLC has remained unclear. This biomarker study from the Phase III NIPPON trial by Hakozaki et al. provides new insights into this topic.

Read now.”

Title: Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)

Authors: Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, Yuta Sekino, Noriko Mitome, Yusuke Okuma, Tomoiki Aiba, Takahiro Utsumi, Junko Tanizaki, Koichi Azuma, Satoshi Hara, Ryo Morita, Seiji Niho, Toshihide Yokoyama, Ryo Toyozawa, Hidehito Horinouchi, Isamu Okamoto, Yukio Hosomi, Yuichiro Ohe

You can read the Full Article in the Journal of Thoracic Oncology.

New Insights from Taiki Hakozaki et al. on Gut Microbiota’s Role in NSCLC - IASLC

More posts featuring IASLC.

cancer chemoimmunotherapy gut microbiota Hidehito Horinouchi IASLC International Association for the Study of Lung Cancer Isamu Okamoto Journal of Thoracic Oncology Junko Tanizaki Kentaro Tanaka Koichi Azuma Lung cancer Noriko Mitome NSCLC OncoDaily Oncology Ryo Morita Ryo Toyozawa Satoshi Hara Seiji Niho Taiki Hakozaki Takahiro Utsumi Tomoiki Aiba Toshihide Yokoyama Yoshimasa Shiraishi Yuichiro Ohe Yukio Hosomi Yusuke Okuma Yuta Sekino
Special Coverage
Insight
Jul 24, 2025, 17:17
New Insights from Taiki Hakozaki et al. on Gut Microbiota’s Role in NSCLC - IASLC
Blog
Jul 24, 2025, 17:03
Oliver Bogler: NIH Grant Research Strategy Blueprint
Blog
Jul 24, 2025, 16:38
Norman Ng: A Breakthrough for Cancer Patients in Hong Kong
Blog
Jul 24, 2025, 16:31
Hana Maheen: Grateful to Have Led the Amazing Volunteer Team at the ESO-OncoDaily Educational Workshop
Insight
Jul 24, 2025, 16:15
Adriana Albini: Combining the Detection of Various Potential Cancer Drivers to Improve Early Identification
Blog
Jul 24, 2025, 16:11
Yan Leyfman: Boosting CAR-T/NK Cell Persistence via the FAS Pathway
Blog
Jul 24, 2025, 16:06
A New Online Tool is Helping Doctors Better Predict Relapse Risk in Early-Stage Hodgkin Lymphoma
Blog
Jul 24, 2025, 15:52
Karan Cushman: Arif Kamal's Personal Journey that Led Him to Palliative Care and Oncology
Blog
Jul 24, 2025, 15:47
Is the Promise of AI and Mathematical Oncology in Personalised Medicine Overhyped? - ESTRO
Blog
Jul 24, 2025, 15:41
Alexandra Barreto: Bringing Essential Palliative Care Practice to Brazil
Career
Jul 24, 2025, 15:34
Boris Pasche: Benjamin Herring has been Appointed Vice President and Associate Center Director of Research Administration at Karmanos
Career
Jul 24, 2025, 15:23
Oliver Bogler has been Appointed Scientific Advisor at Barnacle Labs